您当前的位置:首页 > 核医学

应用定量组织速度成像技术结合小剂量多巴酚丁胺负荷试验评价心肌存活性

时间:2006-01-12 22:22:35  来源:  作者:

Assessing myocardial viability in patients with myocardial infarction by quantitative tissue velocity imaging during low-dose dobutamine stress<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />

 

毕小军 邓又斌 常青 白娇 刘红云 杨好意 刘娅妮 黎春雷

BI Xiao-Jun, DENG You-Bin, CHANG Qing, et al. Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

 

Abstract

Objective:To assess myocardial viability in patients with myocardial infarction by quantitative tissue velocity imaging(QTVI) during low-dose dobutamine stress echocardiography(LDDSE).

Methods:Twenty patients with myocardial infarction underwent percutaneous transluminal coronary angioplasty(PTCA) or PTCA plus stent. LDDSE were performed before operation. QTVI was used to acquire the velocity and displacement curves of impaired myocardium before and during LDDSE and after operation. The strain(S) and strain rate(SR) of impaired myocardium were measured.

Results:In the group that myocardium was survived, both low-dose dobutamine stress and PTCA can significantly raise the SR and S of the impaired myocardium. At the end of low-dose (10μg·kg-1·min-1) dobutamine stress, the magnitudes of SR and S were significant higher than that at rest(SR:1.0±0.4s-1 vs 0.2±0.2 s-1, P<0.01;S:0.1±0.05 vs 0.03±0.01, P<0.01). There was no significant difference between the magnitudes of SR and S at the end of low-dose dobutamine stress and those after PTCA(SR:1.0±0.4 s-1 vs 0.8±0.2 s-1, P>0.05;S:0.1±0.05 vs 0.1±0.04, P>0.05). But in the group that myocardium was not survived, neither the low-dose dobutamine stress nor PTCA can significantly raise the SR and S of the myocardium.

Conclusions:QTVI can assess myocardial viability during LDDSE.

Key words:quantitative tissue velocity imaging, dobutamine, myocardial infarction, myocardial viability

来顶一下
返回首页
返回首页
 
推荐资讯
掌间筑未来,西门子医疗推出全新CT产品SOMATOM go.
掌间筑未来,西门子医疗
“智”动创新 共享“健康中国” 西门子医疗亮相2017 HOSPEQ
“智”动创新 共享“
西门子医疗携一系列创新成果亮相CMEF 2017   助力“智慧”医疗服务建设
西门子医疗携一系列创
西门子医疗中国亮相第77届中国国际医疗器械春季博览会,多方位展示互联网时代下 “智慧”成果
西门子医疗中国亮相第
最后更新
热门点击
  1. 21世纪核医学需要什么样的技术人员?
  2. 渗透压对对比剂肾病发生率的影响:有关在高
  3. 核医学技师出路在何方?对核医学技术人员队伍
  4. PET-CT在肾上腺肿瘤诊断中的诊断效能和判读
  5. 核医学:传统经典的新兴学科
  6. 冠状动脉造影、心电图、核素检查对冠心病诊
  7. 核医学检查对人体有伤害吗?
  8. 《走进核医学》教学录相片的制作
  9. 高分辨率 MRI 可确诊大脑前动脉夹层
  10. 内皮抑素基因联合放射治疗对大鼠Walker-256